(FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | (Q3)Mar 31, 2022 | (FY)Dec 31, 2021 | (Q9)Sep 30, 2021 | |
---|---|---|---|---|---|---|---|---|---|---|
Turnover | 12.72%92.93B | 20.91%69.86B | -2.12%44.89B | -15.49%21.98B | -7.57%82.44B | -6.60%57.78B | 23.65%45.86B | 27.61%26.01B | 19.53%89.2B | 12.57%61.86B |
Operating income | 10.22%80.08B | 20.91%69.86B | -3.69%38.66B | -15.49%21.98B | -4.26%72.65B | -6.60%57.78B | 26.89%40.14B | 27.61%26.01B | 23.27%75.89B | 12.57%61.86B |
Cost of sales | -7.01%-81.61B | ---- | 2.28%-39.75B | ---- | -2.65%-76.27B | ---- | -31.95%-40.68B | ---- | -20.03%-74.3B | ---- |
Operating expenses | -7.01%-81.61B | -15.00%-58.96B | 2.28%-39.75B | 12.75%-18.61B | -2.65%-76.27B | -6.78%-51.27B | -31.95%-40.68B | -41.41%-21.33B | -20.03%-74.3B | -7.80%-48.01B |
Gross profit | 57.50%-1.53B | 67.44%10.9B | -102.27%-1.09B | -27.99%3.37B | -327.02%-3.61B | -52.98%6.51B | -167.08%-539.03M | -11.72%4.67B | 567.53%1.59B | 32.97%13.85B |
Selling expenses | -7.30%-315.54M | -7.63%-227.36M | 16.02%-150.74M | 23.40%-71.09M | 20.14%-294.07M | 34.49%-211.24M | 14.39%-179.49M | 13.88%-92.81M | 24.28%-368.24M | 7.57%-322.45M |
Administrative expenses | ---- | 11.75%-1.4B | ---- | 14.58%-521.34M | ---- | 43.93%-1.59B | ---- | 29.42%-610.34M | ---- | -27.91%-2.83B |
Research and development expenses | ---- | -35.48%-112.34M | ---- | -159.34%-30.78M | ---- | -10.33%-82.92M | ---- | 3.02%-11.87M | ---- | -28.26%-75.15M |
Profit from asset sales | ---- | 140.87%434K | ---- | ---- | ---- | -101.34%-1.06M | ---- | -26,675.00%-1.06M | ---- | -22.88%79.09M |
Revaluation surplus | ---- | ---- | ---- | ---- | ---- | -93.33%1.82M | ---- | -176.00%-17.1M | ---- | 651.67%27.28M |
-Changes in the fair value of other assets | ---- | ---- | ---- | ---- | ---- | -93.33%1.82M | ---- | -176.00%-17.1M | ---- | 651.67%27.28M |
Impairment and provision | ---- | -7.72%-288.54M | ---- | -37.46%48.11M | ---- | -146.91%-267.86M | ---- | --76.93M | -101.12%-1.36M | 10.29%-108.49M |
-Other impairment is provision | ---- | -7.72%-288.54M | ---- | -37.46%48.11M | ---- | -146.91%-267.86M | ---- | --76.93M | -101.12%-1.36M | 10.29%-108.49M |
Special items of operating profit | 56.89%97.39M | -11.18%-680.66M | 2.37%34.49M | -2.41%-157.41M | -70.59%62.08M | -176.23%-612.22M | -77.69%33.69M | -159.02%-153.71M | -11.84%211.07M | 53.97%803.07M |
Adjustment items of operating profit | ---- | 10.17%484.38M | ---- | ---- | ---- | --439.66M | ---- | ---- | ---- | ---- |
Operating profit | 54.39%-1.75B | 65.85%-949.79M | -76.18%-1.21B | -234.81%-222.43M | -368.35%-3.84B | -224.74%-2.78B | -191.93%-684.84M | -88.14%165M | 407.19%1.43B | 289.36%2.23B |
Financing income | -29.13%383.99M | ---- | -43.81%185.05M | ---- | 6.50%541.83M | ---- | 32.35%329.31M | ---- | 17.98%508.76M | ---- |
Financing cost | -47.52%-145.31M | -52.25%178.66M | -11.00%-55.55M | -58.27%61.3M | -4.58%-98.5M | 31.64%374.14M | -30.66%-50.04M | 29.46%146.9M | 4.82%-94.19M | 22.51%284.21M |
Special items of earning before tax | 18.71%-141.13M | 44.76%-26.66M | -311.68%-113.36M | -373.33%-3.16M | -119.86%-173.62M | 21.54%-48.26M | -104.69%-27.54M | 133.06%1.16M | 20.63%874.29M | -55.54%-61.52M |
Earning before tax | 53.68%-1.66B | 67.51%-797.8M | -174.85%-1.19B | -152.48%-164.28M | -231.33%-3.57B | -200.12%-2.46B | -128.07%-433.11M | -79.14%313.05M | 360.59%2.72B | 348.97%2.45B |
Tax | -58.15%306.09M | -82.28%81.14M | 1,828.97%226.29M | 101.98%1.94M | 213.50%731.46M | 195.19%457.77M | 104.49%11.73M | 69.96%-97.83M | -1,082.14%-644.48M | -236.45%-480.88M |
After-tax profit from continuing operations | 52.53%-1.35B | 64.12%-716.66M | -128.80%-964.1M | -175.43%-162.35M | -236.87%-2.84B | -201.32%-2B | -132.88%-421.38M | -81.69%215.22M | 216.36%2.08B | 411.66%1.97B |
Earning after tax | 52.53%-1.35B | 64.12%-716.66M | -128.80%-964.1M | -175.43%-162.35M | -236.87%-2.84B | -201.32%-2B | -132.88%-421.38M | -81.69%215.22M | 216.36%2.08B | 411.66%1.97B |
Minority profit | -182.07%-3.17M | -38.11%2.79M | -49.90%2.59M | -39.51%796K | 21.54%3.86M | -29.06%4.51M | -0.15%5.17M | -26.48%1.32M | -71.97%3.18M | -34.33%6.35M |
Profit attributable to shareholders | 52.70%-1.35B | 64.06%-719.45M | -126.63%-966.69M | -176.27%-163.14M | -237.26%-2.85B | -201.88%-2B | -133.42%-426.55M | -81.77%213.91M | 221.43%2.07B | 405.98%1.97B |
Basic earnings per share | 52.47%-0.125 | 63.78%-0.067 | -130.77%-0.09 | -175.00%-0.015 | -236.98%-0.263 | -201.65%-0.185 | -133.05%-0.039 | -81.48%0.02 | 220.00%0.192 | 408.47%0.182 |
Diluted earnings per share | 52.47%-0.125 | 63.78%-0.067 | -130.77%-0.09 | -175.00%-0.015 | -236.98%-0.263 | -201.65%-0.185 | -133.05%-0.039 | -81.48%0.02 | 220.00%0.192 | 408.47%0.182 |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | IAS | CAS (2007) | IAS | CAS (2007) | IAS | CAS (2007) | IAS | CAS (2007) | IAS | CAS (2007) |
Audit Opinions | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- |
Auditor | KPMG Huazhen Certified Public Accountants (Special General Partnership), KPMG Certified Public Accountants | -- | -- | -- | KPMG Huazhen Certified Public Accountants (Special General Partnership), KPMG Certified Public Accountants | -- | -- | -- | KPMG Huazhen Certified Public Accountants (Special General Partnership), KPMG Certified Public Accountants | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data
No Data